Fingerprint
Dive into the research topics of 'Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
Mohammad H Pourgholami, Michael Szwajcer, Melvin Chin, Winston Liauw, Jonathan Seef, Peter Galettis, David L Morris, Matthew Links
Research output: Contribution to journal › Article › Research › peer-review
59
Citations
(Scopus)